CHRISTINE LEE: Open Payments
NPI 1538941638 · STOCKTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,560 in 103 payments from 15 companies in 2025. Trend: 2023 $291 · 2024 $2,183 · 2025 $2,560
Food & beverage: $2,512Education: $48
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $417 |
| E.R. Squibb & Sons, L.L.C. | 13 | $350 |
| Incyte Corporation | 15 | $324 |
| Arcutis Biotherapeutics, Inc. | 23 | $306 |
| ABBVIE INC. | 21 | $290 |
| GENZYME CORPORATION | 3 | $278 |
| PFIZER INC. | 6 | $246 |
| Regeneron Healthcare Solutions, Inc. | 4 | $105 |
| Amgen Inc. | 3 | $77 |
| Organon LLC | 3 | $49 |
Products named: TREMFYA, DUPIXENT, Sotyktu, OPZELURA, Zoryve, SKYRIZI, CIBINQO, Otezla.
Industry payments across CA — which companies pay providers there.
